Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Harold KE"'
Autor:
Anoop Enjeti, Asma Ashraf, Vincent Caillet, Arif Alam, Jonathan Silar, Harold Keer, Francesco Castaldi, Taleisha Paine
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 527-534 (2024)
Abstract Hypomethylating agents are the most widely used upfront therapy for patients with myelodysplastic syndrome (MDS) who are not suitable for hematopoietic stem cell transplantation. In Australia, azacitidine was, until recently, the only approv
Externí odkaz:
https://doaj.org/article/eb3418dc2d8e4fc28c8fd40e2af57c9f
Autor:
Ekaterina Jahn, Maral Saadati, Pierre Fenaux, Marco Gobbi, Gail Roboz, Lars Bullinger, Pavlo Lutsik, Anna Riedel, Christoph Plass, Nikolaus Jahn, Claudia Walter, Karlheinz Holzmann, Yong Hao, Sue Naim, Nicholas Schreck, Julia Krzykalla, Axel Benner, Harold Keer, Mohammad Azab, Konstanze Döhner, Hartmut Döhner
Publikováno v:
HemaSphere, Vol 7, p e09006a7 (2023)
Externí odkaz:
https://doaj.org/article/4c2e871905fb42089d1303d5857af0bd
Autor:
Guillermo Garcia-Manero, Kimo Bachishvili, Elizabeth A. Griffiths, Amer M. Zeidan, Elie Traer, Lalit Saini, Harshad Amin, Sanjay Mohan, Michael Lübbert, Lori Maness-Harris, James M Foran, Dominik Selleslag, Blanca Xicoy Cirici, Daniel Aaron Pollyea, David Sallman, Aref Al-Kali, Jesus Berdeja, Haifa Kathrin Al-Ali, Nancy Y Zhu, Patricia Font Lopez, Guillermo Sanz Santillana, Valeria Santini, Habte A. Yimer, Larry D Cripe, Victor Priego, Olatoyosi Odenike, Bert Heyrman, David Valcarcel, Pankit Vachhani, Yuri Sano, Beloo Mirakhur, Aram Oganesian, Harold Keer, Abdulraheem Yacoub
Publikováno v:
HemaSphere, Vol 7, p e551265b (2023)
Externí odkaz:
https://doaj.org/article/c645340b1872424db531617d804b3c67
Autor:
Michael Robert Savona, James K Mccloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, H. Joachim Deeg, Prapti A. Patel, Mitchell Sabloff, Mary-Margaret Keating, Nancy Y Zhu, Nashat Gabrail, Salman Fazal, Joseph J. Maly, Olatoyosi Odenike, Hagop Kantarjian, Amy Dezern, Casey L Oconnell, Gail Roboz, Lambert Busque, Rena Buckstein, Harshad Amin, Jasleen K Randhawa, Brian Leber, Kim-Hien Dao, Winny Chan, Aram Oganesian, Yuri Sano, Beloo Mirakhur, Harold Keer, Guillermo Garcia-Manero
Publikováno v:
HemaSphere, Vol 7, p e1342620 (2023)
Externí odkaz:
https://doaj.org/article/d714ae49ea90429fa3bcf0183321b904
Publikováno v:
HemaSphere, Vol 7, p e81919d4 (2023)
Externí odkaz:
https://doaj.org/article/1290a909f1d9420fbd164938347d1a00
Autor:
Jake Shortt, Brian Poligone, Vincent Ribrag, Pier Luigi Zinzani, Dima El-Sharkawi, Jan Walewski, Anca Prica, Laksmi Wilson, Sonia Souza, Harold Keer, Jason Taylor, Enrica Marchi
Publikováno v:
HemaSphere, Vol 7, p e07947e7 (2023)
Externí odkaz:
https://doaj.org/article/c7565cf856fb48a590bbc2729f8d6fef
Autor:
Manish A Shah, Zev A Wainberg, Daniel V T Catenacci, Howard S Hochster, James Ford, Pamela Kunz, Fa-Chyi Lee, Howard Kallender, Fabiola Cecchi, Daniel C Rabe, Harold Keer, Anne-Marie Martin, Yuan Liu, Robert Gagnon, Peter Bonate, Li Liu, Tona Gilmer, Donald P Bottaro
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0276211 (2022)
[This corrects the article DOI: 10.1371/journal.pone.0054014.].
Externí odkaz:
https://doaj.org/article/59c2c84b825f40d781e74d4c8add9f83
Autor:
Manish A Shah, Zev A Wainberg, Daniel V T Catenacci, Howard S Hochster, James Ford, Pamela Kunz, Fa-Chyi Lee, Howard Kallender, Fabiola Cecchi, Daniel C Rabe, Harold Keer, Anne-Marie Martin, Yuan Liu, Robert Gagnon, Peter Bonate, Li Liu, Tona Gilmer, Donald P Bottaro
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0261994 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0054014.].
Externí odkaz:
https://doaj.org/article/3a8c73388258421cbed41f983d337c90
Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent.
Autor:
Manjusha Thakar, Yue Hu, Michael Morreale, Lane Lerner, Wan Ying Lin, Rupashree Sen, Yi Cai, Enusha Karunasena, Maya Thakar, Soren Saggi, Harold Keer, Nita Ahuja
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242974 (2020)
[This corrects the article DOI: 10.1371/journal.pone.0199130.].
Externí odkaz:
https://doaj.org/article/7b6151736b014cb78528ca0e456319b8
Autor:
Manjusha Thakar, Yue Hu, Michael Morreale, Lane Lerner, Wan Ying Lin, Rupashree Sen, Yi Cai, Enusha Karunasena, Maya Thakar, Soren Saggi, Harold Keer, Nita Ahuja
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0199130 (2018)
Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second leading cause of cancer mortality by 2030. PDAC remains resistant to the majority of systemic chemotherapies. In this paper, we explore if epigenetic sensitization can improve chemo
Externí odkaz:
https://doaj.org/article/c3ccffdba6304964815c74ae8b08da86